Cross-Presentation Assay for Human Dendritic Cells

  • Elodie SeguraEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1423)


The presentation of exogenous antigens on major histocompatibility complex (MHC) class I molecules, termed cross-presentation, is essential for the initiation of cytotoxic immune responses. Numerous studies in mice and human have shown that dendritic cells are the best cross-presenting cells. The protocol described here allows the assessment of the cross-presentation by human dendritic cells of a model antigen (either soluble or cell associated) to antigen-specific CD8 T cells.

Key words

Dendritic cells Cross-presentation Antigen processing Human CD8 T cells 



This work is supported by INSERM, the European Research Council, Labex DCBIOL, and Ligue contre le Cancer.


  1. 1.
    Joffre OP, Segura E, Savina A, Amigorena S (2012) Cross-presentation by dendritic cells. Nat Rev Immunol 12(8):557–569CrossRefPubMedGoogle Scholar
  2. 2.
    Albert ML, Sauter B, Bhardwaj N (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392(6671):86–89CrossRefPubMedGoogle Scholar
  3. 3.
    Segura E, Amigorena S (2014) Cross-presentation by human dendritic cell subsets. Immunol Lett 158(1–2):73–78CrossRefPubMedGoogle Scholar
  4. 4.
    Segura E, Durand M, Amigorena S (2013) Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells. J Exp Med 210(5):1035–1047CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM (2002) Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 196(12):1627–1638CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, Soares H, Brimnes MK, Moltedo B, Moran TM, Steinman RM (2004) In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 199(6):815–824CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Tacken PJ, de Vries IJ, Torensma R, Figdor CG (2007) Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol 7(10):790–802CrossRefPubMedGoogle Scholar
  8. 8.
    Caminschi I, Lahoud MH, Shortman K (2009) Enhancing immune responses by targeting antigen to DC. Eur J Immunol 39(4):931–938CrossRefPubMedGoogle Scholar
  9. 9.
    Sancho D, Mourao-Sa D, Joffre OP, Schulz O, Rogers NC, Pennington DJ, Carlyle JR, Reis e Sousa C (2008) Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest 118(6):2098–2110CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Idoyaga J, Lubkin A, Fiorese C, Lahoud MH, Caminschi I, Huang Y, Rodriguez A, Clausen BE, Park CG, Trumpfheller C, Steinman RM (2011) Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc Natl Acad Sci U S A 108(6):2384–2389CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Yssel H, De Vries JE, Koken M, Van Blitterswijk W, Spits H (1984) Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J Immunol Methods 72(1):219–227CrossRefPubMedGoogle Scholar
  12. 12.
    Tel J, Schreibelt G, Sittig SP, Mathan TS, Buschow SI, Cruz LJ, Lambeck AJ, Figdor CG, de Vries IJ (2013) Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets. Blood 121(3):459–467CrossRefPubMedGoogle Scholar
  13. 13.
    Faure F, Mantegazza A, Sadaka C, Sedlik C, Jotereau F, Amigorena S (2009) Long-lasting cross-presentation of tumor antigen in human DC. Eur J Immunol 39(2):380–390CrossRefPubMedGoogle Scholar
  14. 14.
    Mittag D, Proietto AI, Loudovaris T, Mannering SI, Vremec D, Shortman K, Wu L, Harrison LC (2011) Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. J Immunol 186(11):6207–6217CrossRefPubMedGoogle Scholar
  15. 15.
    Bachem A, Guttler S, Hartung E, Ebstein F, Schaefer M, Tannert A, Salama A, Movassaghi K, Opitz C, Mages HW, Henn V, Kloetzel PM, Gurka S, Kroczek RA (2010) Superior antigen cross-presentation and XCR1 expression define human CD11c + CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med 207(6):1273–1281CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, Chen CJ, Dunbar PR, Wadley RB, Jeet V, Vulink AJ, Hart DN, Radford KJ (2010) Human CD141+ (BDCA-3) + dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 207(6):1247–1260CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Accapezzato D, Visco V, Francavilla V, Molette C, Donato T, Paroli M, Mondelli MU, Doria M, Torrisi MR, Barnaba V (2005) Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo. J Exp Med 202(6):817–828CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Haniffa M, Shin A, Bigley V, McGovern N, Teo P, See P, Wasan PS, Wang XN, Malinarich F, Malleret B, Larbi A, Tan P, Zhao H, Poidinger M, Pagan S, Cookson S, Dickinson R, Dimmick I, Jarrett RF, Renia L, Tam J, Song C, Connolly J, Chan JK, Gehring A, Bertoletti A, Collin M, Ginhoux F (2012) Human tissues contain CD141(hi) cross-presenting dendritic cells with functional homology to mouse CD103(+) nonlymphoid dendritic cells. Immunity 37(1):60–73CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.INSERM U932, and Institut Curie, Centre de rechercheParis Cedex 05France

Personalised recommendations